Your browser doesn't support javascript.
loading
An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates.
Wu, Shipo; Kroeker, Andrea; Wong, Gary; He, Shihua; Hou, Lihua; Audet, Jonathan; Wei, Haiyan; Zhang, Zhe; Fernando, Lisa; Soule, Geoff; Tran, Kaylie; Bi, Shengli; Zhu, Tao; Yu, Xuefeng; Chen, Wei; Qiu, Xiangguo.
Afiliação
  • Wu S; Beijing Institute of Biotechnology.
  • Kroeker A; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
  • Wong G; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
  • He S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
  • Hou L; Beijing Institute of Biotechnology.
  • Audet J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
  • Wei H; Institute of Infectious Disease, Henan Centre for Disease Control, Zhengzhou.
  • Zhang Z; Beijing Institute of Biotechnology.
  • Fernando L; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada.
  • Soule G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada.
  • Tran K; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada.
  • Bi S; Institute of Viral Disease, China Center for Disease Control and Prevention, Beijing.
  • Zhu T; Tianjin CanSino Biotechnology, China.
  • Yu X; Tianjin CanSino Biotechnology, China.
  • Chen W; Beijing Institute of Biotechnology.
  • Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
J Infect Dis ; 214(suppl 3): S326-S332, 2016 10 15.
Article em En | MEDLINE | ID: mdl-27493239

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Virais / Imunização / Doença pelo Vírus Ebola / Vacinas contra Ebola / Ebolavirus / Vacinas contra Adenovirus Limite: Animals / Humans País/Região como assunto: Africa / Asia Idioma: En Revista: J Infect Dis Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Virais / Imunização / Doença pelo Vírus Ebola / Vacinas contra Ebola / Ebolavirus / Vacinas contra Adenovirus Limite: Animals / Humans País/Região como assunto: Africa / Asia Idioma: En Revista: J Infect Dis Ano de publicação: 2016 Tipo de documento: Article